Walbert Keli bought COAG
September 24, 2026 · Form 4 insider transaction
Walbert Keli bought 36,000 shares of Hemab Therapeutics Holdings, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
36,000
Price
$0.00
Total value
N/A
InsiderWalbert Keli
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateSeptember 24, 2026
Filing dateSeptember 25, 2026
Shares owned after36,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option was granted on September 24, 2026. The shares underlying the option are scheduled to vest over three years in equal monthly installments from September 24, 2026 through September 24, 2029, subject to continuous service.